These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12433308)

  • 21. Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release.
    Gasper MM; Blanco D; Cruz ME; Alonso MJ
    J Control Release; 1998 Mar; 52(1-2):53-62. PubMed ID: 9685935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Composition and surface charge of DNA-loaded microparticles determine maturation and cytokine secretion in human dendritic cells.
    Jilek S; Ulrich M; Merkle HP; Walter E
    Pharm Res; 2004 Jul; 21(7):1240-7. PubMed ID: 15290866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
    Pollauf EJ; Kim KK; Pack DW
    J Pharm Sci; 2005 Sep; 94(9):2013-22. PubMed ID: 16052542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mechanism of PLA microparticle formation by water-in-oil-in-water solvent evaporation method.
    Chen JL; Chiang CH; Yeh MK
    J Microencapsul; 2002; 19(3):333-46. PubMed ID: 12022499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
    Chaw CS; Yang YY; Lim IJ; Phan TT
    J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of hepatitis B oral vaccine using B-cell epitope loaded PLG microparticles.
    Rajkannan R; Dhanaraju MD; Gopinath D; Selvaraj D; Jayakumar R
    Vaccine; 2006 Jun; 24(24):5149-57. PubMed ID: 16713035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles.
    Vordermeier HM; Coombes AG; Jenkins P; McGee JP; O'Hagan DT; Davis SS; Singh M
    Vaccine; 1995 Nov; 13(16):1576-82. PubMed ID: 8578845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method.
    Coombes AG; Yeh MK; Lavelle EC; Davis SS
    J Control Release; 1998 Mar; 52(3):311-20. PubMed ID: 9743451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.
    Prior S; Gamazo C; Irache JM; Merkle HP; Gander B
    Int J Pharm; 2000 Feb; 196(1):115-25. PubMed ID: 10675713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen.
    Coombes AG; Lavelle EC; Jenkins PG; Davis SS
    Vaccine; 1996 Oct; 14(15):1429-38. PubMed ID: 8994318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of CTAB concentration in cationic PLG microparticles on DNA adsorption and in vivo performance.
    Singh M; Ugozzoli M; Briones M; Kazzaz J; Soenawan E; O'Hagan DT
    Pharm Res; 2003 Feb; 20(2):247-51. PubMed ID: 12636163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immune response to a model antigen associated with PLG microparticles prepared using different surfactants.
    Rafati H; Lavelle EC; Coombes AG; Stolnik S; Holland J; Davis SS
    Vaccine; 1997 Dec; 15(17-18):1888-97. PubMed ID: 9413098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation, physiochemical characterization, and oral immunogenicity of Abeta(1-12), Abeta(29-40), and Abeta(1-42) loaded PLG microparticles formulations.
    Rajkannan R; Arul V; Malar EJ; Jayakumar R
    J Pharm Sci; 2009 Jun; 98(6):2027-39. PubMed ID: 18980172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles.
    O'Hagan DT; Jeffery H; Davis SS
    Vaccine; 1993; 11(9):965-9. PubMed ID: 8212845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An investigation of the factors controlling the adsorption of protein antigens to anionic PLG microparticles.
    Chesko J; Kazzaz J; Ugozzoli M; O'hagan DT; Singh M
    J Pharm Sci; 2005 Nov; 94(11):2510-9. PubMed ID: 16200615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of poly(acryl starch) and poly(lactide-co-glycolide) microspheres as drug delivery system for a rotavirus vaccine.
    Sturesson C; Degling Wikingsson L
    J Control Release; 2000 Sep; 68(3):441-50. PubMed ID: 10974398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
    Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
    Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments.
    Coombes AG; Tasker S; Lindblad M; Holmgren J; Hoste K; Toncheva V; Schacht E; Davies MC; Illum L; Davis SS
    Biomaterials; 1997 Sep; 18(17):1153-61. PubMed ID: 9259512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of Japanese encephalitis virus vaccine loaded poly(L-lactide-co-glycolide) microspheres for oral immunization.
    Khang G; Cho JC; Lee JW; Rhee JM; Lee HB
    Biomed Mater Eng; 1999; 9(1):49-59. PubMed ID: 10436853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
    Jiang G; Qiu W; DeLuca PP
    Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.